Groundbreaking research that may have important implications for
liver cancer treatment has secured a prestigious award for a Cancer
Research UK scientist.
Dr Simon Boulton, a Senior Group Leader at Cancer Research UK's
London Research Institute (now part of the Francis Crick
Institute), was awarded the 2011 European Molecular Biology Organization (EMBO) Gold
Medal on 20 April. This annual award recognises the outstanding
contributions of young researchers in the molecular life
sciences.
The Senior Group Leader at Cancer Research UK's London Research
Institute received the award in recognition of his groundbreaking
research on DNA repair mechanisms. The election committee was
particularly impressed by his pioneering role in establishing the
nematode worm, C. elegans, as a model system to study
genome instability.
On hearing the news Dr Boulton said: "I am delighted and
honoured to receive such a prestigious award."
Cancer Research UK is part of the consortium behind the UK
Centre for Medical Research and Innovation (UKCMRI). The London
Research Institute is one of the founding institutes of UKCMRI -
its scientists will work with colleagues from the MRC's National
Institute for Medical Research when the new laboratories open in
2015.
UKCMRI is an unprecedented partnership between four of the
world's leading biomedical research organisations: the Medical
Research Council, Cancer Research UK, the Wellcome Trust and UCL
(University College London). It will carry out research of the
highest quality using the latest technology to advance
understanding of human health and disease.
The institute will be constructed on 3.6 acres of land at Brill
Place, to the north of the British Library in the St Pancras and
Somers Town area of north London.